According to ICRA, India’s pharmaceutical sector is likely to witness revenue growth of 7-9% in FY26, driven by robust demand […]
Obesity medicines, which were considered to be an specialty product sold to metropolitan elites, are turning out to be the […]
Sanofi recently announced its plan to acquire Dynavax for $2.2 billion, despite not being completed yet. This acquisition is expected […]